If you had lung cancer, you’d take one kind of drug. If you had liver cancer, you’d take another drug. Makes sense, right? But scientists have found another, more effective, more targeted way to treat cancer — one that you need a code to unlock. In this episode we look at the surprising history and the hopeful future of immunotherapy, and how the genetic code of cancer itself has been used to find a way to treat the disease.

Featuring:

• Neeha Zaidi is a medical oncologist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre. 
• Mike Yee is Jefferies’ managing director and senior biotech analyst
• Neville Sanjana is a core faculty member at the New York genome center and also an assistant professor of biology at NYU